» Articles » PMID: 34439488

Adaption to Auranofin: A Phenotypic and Multi-Omics Characterization

Overview
Date 2021 Aug 27
PMID 34439488
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Auranofin (AF), an antirheumatic agent, targets mammalian thioredoxin reductase (TrxR), an important enzyme controlling redox homeostasis. AF is also highly effective against a diversity of pathogenic bacteria and protozoan parasites. Here, we report on the resistance of the parasite to 2 µM of AF that was acquired by gradual exposure of the parasite to an increasing amount of the drug. AF-adapted trophozoites (AFAT) have impaired growth and cytopathic activity, and are more sensitive to oxidative stress (OS), nitrosative stress (NS), and metronidazole (MNZ) than wild type (WT) trophozoites. Integrated transcriptomics and redoxomics analyses showed that many upregulated genes in AFAT, including genes encoding for dehydrogenase and cytoskeletal proteins, have their product oxidized in wild type trophozoites exposed to AF (acute AF trophozoites) but not in AFAT. We also showed that the level of reactive oxygen species (ROS) and oxidized proteins (OXs) in AFAT is lower than that in acute AF trophozoites. Overexpression of TrxR (EhTrxR) did not protect the parasite against AF, which suggests that EhTrxR is not central to the mechanism of adaptation to AF.

Citing Articles

Identification and characterization of archaeal-type FAD synthase as a novel tractable drug target from the parasitic protozoa .

Wulansari D, Jeelani G, Yazaki E, Nozaki T mSphere. 2024; 9(9):e0034724.

PMID: 39189775 PMC: 11423594. DOI: 10.1128/msphere.00347-24.


Identification of Small Molecule Inhibitors Targeting Phosphoserine Phosphatase: A Novel Target for the Development of Antiamoebic Drugs.

Kumari P, Agrawal P, Umarao P, Ramachandran V, Gourinath S ACS Omega. 2024; 9(26):27906-27918.

PMID: 38973836 PMC: 11223228. DOI: 10.1021/acsomega.3c09439.


Genes differentially expressed between pathogenic and non-pathogenic Entamoeba histolytica clones influence pathogenicity-associated phenotypes by multiple mechanisms.

Anders J, Konig C, Lender C, Hellhund A, Nehls S, Shalabi I PLoS Pathog. 2023; 19(12):e1011745.

PMID: 38134215 PMC: 10773965. DOI: 10.1371/journal.ppat.1011745.


Structure of 6-Phosphogluconate Dehydrogenase and Inhibition by Phosphine Gold(I) Complexes: A Potential Approach to Leishmaniasis Treatment.

Berneburg I, Stumpf M, Velten A, Rahlfs S, Przyborski J, Becker K Int J Mol Sci. 2023; 24(10).

PMID: 37239962 PMC: 10217883. DOI: 10.3390/ijms24108615.


Insights into the Role of Oxidative Stress and Reactive Oxygen Species in Parasitic Diseases.

Ankri S Antioxidants (Basel). 2023; 12(5).

PMID: 37237875 PMC: 10215486. DOI: 10.3390/antiox12051010.


References
1.
Froscio M, Murray A, Hurst N . Inhibition of protein kinase C activity by the antirheumatic drug auranofin. Biochem Pharmacol. 1989; 38(13):2087-9. DOI: 10.1016/0006-2952(89)90061-0. View

2.
Konig C, Meyer M, Lender C, Nehls S, Wallaschkowski T, Holm T . An Alcohol Dehydrogenase 3 (ADH3) from Is Involved in the Detoxification of Toxic Aldehydes. Microorganisms. 2020; 8(10). PMC: 7594077. DOI: 10.3390/microorganisms8101608. View

3.
Shaulov Y, Nagaraja S, Sarid L, Trebicz-Geffen M, Ankri S . Formation of oxidised (OX) proteins in Entamoeba histolytica exposed to auranofin and consequences on the parasite virulence. Cell Microbiol. 2020; 22(6):e13174. DOI: 10.1111/cmi.13174. View

4.
Hashemi S, Farajzadeh Sheikh A, Goodarzi H, Yadyad M, Seyedian S, Aslani S . Genetic basis for metronidazole and clarithromycin resistance in strains isolated from patients with gastroduodenal disorders. Infect Drug Resist. 2019; 12:535-543. PMC: 6404679. DOI: 10.2147/IDR.S192942. View

5.
Cox J, Mann M . MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008; 26(12):1367-72. DOI: 10.1038/nbt.1511. View